CREON 1212 Pill - brown clear capsule/oblong, 18mm

Generic Name: pancrelipase

Pill with imprint CREON 1212 is Brown / Clear, Capsule/Oblong and has been identified as Creon 60,000 units amylase / 12,000 units lipase / 38,000 units protease. It is supplied by Solvay Pharmaceuticals Inc.

Creon is used in the treatment of Pancreatic Exocrine Dysfunction; Chronic Pancreatitis; Cystic Fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 60,000 units amylase / 12,000 units lipase / 38,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1212

Creon 60,000 units amylase / 12,000 units lipase / 38,000 units protease CREON 1212

Creon 60,000 units amylase / 12,000 units lipase / 38,000 units protease CREON 1212 Front

Creon 60,000 units amylase / 12,000 units lipase / 38,000 units protease CREON 1212 Back

Creon

Generic Name: pancrelipase
Imprint: CREON 1212
Strength: 60,000 units amylase / 12,000 units lipase / 38,000 units protease
Color: Brown / Clear
Size: 18.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Digestive enzymes
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Solvay Pharmaceuticals Inc.
National Drug Code (NDC): 00032-1212
Inactive Ingredients: hypromellose phthalate (31% phthalate, 40 cst), triethyl citrate, ferrosoferric oxide, ferric oxide red, titanium dioxide, sodium lauryl sulfate, ferric oxide yellow, cetyl alcohol, dimethicone
Note: Inactive ingredients may vary.